The Australian Trade and Investment Commission in Korea strengthened its partnership with Australian and Korean biotech and medtech companies through various collaborations and exchanges in 2021.
The highlight of 2021 was the return to a physical Australian national pavilion at the Bio Korea conference in an online/offline hybrid format following 2020’s fully virtual event. Australia’s green and gold national brand made a strong Team Australia presence to the Korean biotech industry.
The Australian Trade and Investment Commission in Korea sought various business proposals for biotech cooperation between Korea and Australia, focusing on collaboration opportunities between the two countries and revitalizing investment in the Australian market. Thanks to this, advanced health/bio technologies of 29 Australian biotech institutions and companies were introduced to the Korean market and throughout 120 online partnering meetings conducted during Bio Korea 2021.
In particular, this year, through the Korea-Australia Open Innovation Showcase for basic research introduction and relay research cooperation as well as clinical trials in Australia, various cooperation opportunities such as ▲ joint research ▲ initial investment ▲ licensing were held.
“2021 marks the 60th anniversary of diplomatic ties between Korea and Australia,” said Julie Quinn, Senior Trade and Investment Commissioner of the Australian Trade and Investment Commission in Korea, adding “In line with this, the Australian Trade and Investment Commission has continued a solid partnership to strengthen Korea-Australia life science and R&D partnerships and create future business opportunities. We will do our best not only to strengthen cooperation in the biotech and health industry but also to pioneer new fields.”.
Julie Quinn also highlighted that, “In 2022, through the Australian government’s support program, we plan to support Korean companies wishing to conduct clinical and various R&D activities in Australia, and significantly strengthen cooperation between Korea and Australia in the field of digital health. The two countries are expected to achieve strong synergies through close cooperation in vaccine research and development, which has become an important issue due to the COVID-19 pandemic as well as development of therapeutics using mRNA and RNA platform technology.”.
The Australian Trade and Investment Commission in Korea will continue active exchange and collaboration activities between Australia and Korea in 2022. Starting with ‘Bio Korea 2022’ (May 11, 2022), ‘AusMedtech 2022’ (May 24-26, 2022) and ‘AusBiotech 2022’ (October 25-28, 2022).